Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GHMXV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ARC-02
|
|||||
| Synonyms |
Anti-CD79b-MMAE ADC; Anti-CD79b-MMAE ADC (Araris Biotech); ARC 02; ARC02
Click to Show/Hide
|
|||||
| Organization |
Araris Biotech AG
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Non Hodgkin lymphoma [ICD11:2B33]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
1.9
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.